期刊
INTERNATIONAL JOURNAL OF OBESITY
卷 40, 期 4, 页码 721-724出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ijo.2016.20
关键词
-
资金
- Mazankowski Alberta Heart Institute
- Libin Cardiovascular Institute
- Alberta Health Services
- Merck Frost Canada Inc
- Roche Canada
- Eli Lilly Canada Inc
- Bristol-Myers Squibb
- Philips Medical Systems Canada
- University of Alberta Hospital Foundation
- Canadian Institute of Health Research-Canadian National Transplant Research Program
The purpose of this study was to compare the outcomes of patients undergoing cardiac transplantation stratified by body mass index (BMI, kg m(-2)). The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry captured 220 cardiac transplantations in Alberta, Canada from January 2004 to April 2013. All recipients were stratified by BMI into five groups (BMI: < 20, 20-24.9, 25-29.9, 30-<34.9 and >= 35). Patient characteristics were analyzed by analysis of variance and chi(2) analyses. Kaplan-Meier was used to examine survival differences. Preoperative characteristics demonstrated significant increases in metabolic syndrome, prior myocardial infarction and prior coronary artery bypass graft in patients with morbid obesity. Intraoperatively, there was an increase in cardiopulmonary bypass time in patients with morbid obesity (P>0.01). Postoperative analysis revealed increased rates of early complications (<30 days), associated with a BMI 435. Long-term survival was also significantly decreased in patients with morbid obesity. Of interest, obesity (BMI, 30-34.9) was not associated with decreased survival. These findings suggest that, post-cardiac transplantation, patients who have a BMI >= 35 have lower long-term survival compared with all other BMI groups. However, patients with BMI 30-34.9 did not have significantly worse outcomes and should not be excluded for heart transplantation based on BMI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据